Release Date: September 30, 2025
Expiration Date: September 30, 2027
Activity Overview
The Burst CME™ format is an online, on-demand program designed to deliver concise modular education. In this third module, Stacy Loeb, MD, MSc, PhD (Hon), discusses the role of multiparametric MRI in prostate cancer risk assessment and ways to apply results to clinical decision-making.
Target Audience
This educational activity is primarily directed toward urologists. Other clinicians who diagnose prostate cancer are welcome to participate as well.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Integrate biomarker testing and magnetic resonance imaging to improve risk stratification and early detection in patients with a high risk of prostate cancer
Stacy Loeb, MD, MSc, PhD (Hon)
Professor of Urology and Population Health
New York University Langone Health
New York, NY
Disclosures: Consulting: Astellas, Savor Health; Ad Board: Blue Earth, Doceree, Endo USA Inc; Grant/Research Funding: Endo USA Inc
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.